Responsible Research

AbbVie is committed to ethical research in all aspects of our business. We maintain the highest standards of clinical practice in all of our research, including bioethics, clinical trial conduct, new technology use, and animal welfare. We are a responsible company, and we will operate ethically in every area of our business, in every corner of the globe.

responsible_research_green

We engage in responsible research practices in our five research centers, including in Ludwigshafen, Germany. 


Bioethics
+

Bioethics influences the complex interaction of human life, science and technology. AbbVie's bioethical principles are consistent with the World Medical Association Declaration of Helsinki. We believe bioethics is an important compass for any health care company's behavior, as it addresses principled issues involving the use of life sciences and technologies for the development and production of biotechnological and pharmaceutical products. We conduct our business in accordance with the highest standards of bioethics, and promote bioethical practices and procedures throughout all areas of our business. We have clear and strong bioethics policies and protocols in place at AbbVie. Our strict policies address:

  • The welfare of our patients
  • The conduct of clinical trials
  • The treatment of animals
  • The confidentiality of personal information
  • The ethical use of new biological and medical knowledge

Biomedical Principles
+

Our biomedical principles are part of our strict corporate policies. These principles are focused on responsible pharmaceutical research including safeguarding the volunteers and patients who participate in clinical trials. We adhere to our strict principles and policies – even when local law stipulates a less robust approach. AbbVie has high standards of quality, safety and transparency at all stages, in all countries where we conduct trials.


Animal Welfare
+

AbbVie is committed to ensuring the humane care and use of laboratory animals in the company’s research and development programs. We recognize that high quality science and humane animal care are inseparable. AbbVie’s laboratory animal research programs and facilities meet and consistently exceed United States and European Union regulations, as well as those in other countries, as applicable. AbbVie has voluntarily sought and maintained accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) for all of our animal programs. For outsourced studies, we preferentially work with contract laboratories that are accredited by AAALAC and/or we perform welfare assessments to assure they meet our high standards for animal care and use.

While animal testing remains part of advancing health care research, AbbVie works to minimize the number of tests by using new methods and programs that minimize the need for animal participation. We are committed to the internationally-accepted standard of the 3Rs (Replacement, Reduction, and Refinement). The AbbVie Alternatives Committee leads this effort and its annual internal awards promote significant contribution to improving the welfare of laboratory animals. AbbVie's Global Animal Welfare Committee guides our policies on animal use, and our Institutional Animal Care and Use Committees serve as review boards to independently evaluate and approve scientific protocols. Non-affiliated members from the community comprise 20% of this committee to represent the public view.


Publishing of Clinical Data
+

Clinical research is a critical component of medical product development. For information about our clinical trials, postmarketing commitments and transparency policy click here.


YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?

EXIT ABBVIE.COM

The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.

As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to continue to this product-specific site?

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?